WCG
TNDM icon

Weaver Consulting Group’s Tandem Diabetes Care TNDM Stock Holding History

Weaver Consulting Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$11K – 829
2020
Q3 		$11K Hold
100
– – 0.01% 551
2020
Q2 		$10K Hold
100
– – 0.01% 547
2020
Q1 		$6K Hold
100
– – ﹤0.01% 540
2019
Q4 		$6K Hold
100
– – ﹤0.01% 582
2019
Q3 		$6K Hold
100
– – ﹤0.01% 563
2019
Q2 		$6K Hold
100
– – ﹤0.01% 551
2019
Q1 		$7K Buy
+100
New +$5.25K ﹤0.01% 1042

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weaver Consulting Group's TNDM Position: Q4 2020 in Review

Weaver Consulting Group sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 100 shares — an estimated $11K sold.

Weaver Consulting Group first reported a position in TNDM in Q1 2019 and held it in 7 quarters. The position peaked at $11K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • Weaver Consulting Group reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 100 Tandem Diabetes Care shares in Q4 2020, an estimated $11K.
  • Weaver Consulting Group first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Tandem Diabetes Care position peaked at $11K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.